X
03Jul

Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR

On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By: Morrison & Foerster LLP
Source Url: https://www.jdsupra.com/legalnews/committed-to-clarity-fda-s-dedication-30852/

Related

Sitting Here on Capitol Hill: Congressional Developments on Life Science and Consumer Product Issues - July 2019 #2

Legislation - Consumer Product Safety: House Committee Approves Six Bills - Responding to what t...

Read More >

The SECURE Act: Implications For Individuals And Small Business Owners

Executive summary- On December 20, 2019, President Trump signed sweeping legislation that materiall...

Read More >

EU-U.S. Privacy Shield: EU Commission Confirms Adequacy but Highlights Room for Improvement

On October 23, 2019, the European Commission published its report after its third annual review on t...

Read More >

New HSR Annual Report Indicates Trends of Agency Challenges to Transactions, Renewed Interest in Healthcare Transactions

The 2018 Hart-Scott-Rodino Annual Report (the 2018 HSR Report), recently released by the Federal Tra...

Read More >

SDNY Grants Motion to Dismiss SOX Retaliation Claim

On September 18, 2019, the U.S. District Court for the Southern District of New York granted a defen...

Read More >

Blog: Cooley’s 2019 Tech M&A Year in Review

In the wake of record-setting volume and value metrics in 2018, practitioners eyed the 2019 deal mar...

Read More >